Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Q3 2022 · 10-Q
Revenue$10.68B$10.68B+14.4% vs Q3 2021 Net Income$1.50B$1.50B−21.3% vs Q3 2021 EPS Diluted$3.79$3.79−20.9% vs Q3 2021 Operating Income$1,710,000,000−24.9% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$1,390,000,000−34.6% Margins · derivedOperating margin16.0%−8.4 pt vs Q3 2021
Net margin14.0%−6.4 pt vs Q3 2021
ended Oct 1, 2022 · filed Nov 4, 2022 · 34 d after period end